Malonic Acid

Malonic Acid

SCHEMBL7146355

COc1cccc(N(C(N)=O)c2ccc3[nH]c(C)c(CCN(C)CCc4ccncc4)c3c2)c1.O=C(O)CC(=O)O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 2/20 0.43
HTR6 P50406 2/20 0.43
HTR1A P08908 1/20 0.43
SLC6A2 P23975 1/20 0.43
HTR1E P28566 1/20 0.43
HTR7 P34969 1/20 0.43
HTR5A P47898 1/20 0.43
KDM4E B2RXH2 1/20 0.42
KMT2A Q03164 4/20 0.41
NPC1 O15118 1/20 0.41
AKR1C2 P52895 1/20 0.41
TBXAS1 P24557 1/20 0.41
MTNR1A P48039 2/20 0.40
MTNR1B P49286 2/20 0.40
MEN1 O00255 3/20 0.40
MAPT P10636 8/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPK1 P28482 1/20 0.39
GAA P10253 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Malonic Acid SCHEMBL7147604 0.94 KDM4E (0.44) HTR1DHTR6HTR1ASLC6A2HTR1E
Malonic Acid SCHEMBL8549235 0.85 MAPT (0.36) KDM4EKMT2ANPC1MTNR1AMTNR1B
Malonic Acid SCHEMBL8550508 0.85 SMN1; SMN2 (0.35) KDM4EMTNR1AMTNR1BMAPTGAA
Malonic Acid SCHEMBL8548541 0.80 MAPT (0.35) KDM4EKMT2ANPC1MTNR1AMTNR1B
Malonic Acid SCHEMBL8552650 0.79 SMN1; SMN2 (0.34) KDM4EMTNR1AMTNR1BMAPTGAA
SCHEMBL7145976 0.77 GNRHR (0.48) HTR1DHTR6HTR1ASLC6A2HTR1E
SCHEMBL7144826 0.72 MAPT (0.45) HTR1DHTR6HTR1ASLC6A2HTR1E
Malonic Acid SCHEMBL8215354 0.70 HTR1F (0.70) HTR1DHTR6HTR1AHTR7KMT2A
Citric Acid SCHEMBL8210184 0.68 HTR1F (0.44) KMT2ATBXAS1MEN1MAPTALDH1A1
SCHEMBL8196218 0.66 HTR1F (0.75) HTR1DHTR6HTR1AHTR7KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0768301-B1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists LILLY CO ELI (US) 2003-04-02 EP disclosed
US-6126932-A INSOLUBLE POLYMER BEARING PENDANT SIDE CHAINS, SAID SIDE CHAINS EACH TERMINATING WITH THE 1-(3-(1-PYRROLIDINYL)-PROPYL)-3-ETHYLCARBODIIMIDE MOIETY. ELI LILLY AND COMPANY (US) 2000-10-03 US disclosed
EP-0994109-A2 1-(3-(1-Pyrrolidinyl)propyl)-3-ethylcarbodiimide and a solid phase coupling agent ELI LILLY AND COMPANY (US) 2000-04-19 EP disclosed
US-5998630-A A 1-(3-(1-PYRROLIDINYL)PROPY)-3-ETHYLCARBODIIMIDE ELI LILLY AND COMPANY (US) 1999-12-07 US disclosed
WO-1997013512-A1 N-[2-SUBSTITUTED-3-(2-AMINOETHYL)-1H-INDOL-5-YL]-AMIDES: NEW 5-HT1F AGONISTS ELI LILLY AND COMPANY (US) 1997-04-17 WO disclosed
EP-0768301-A1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists ELI LILLY AND COMPANY (US) 1997-04-16 EP disclosed